anonymous
Guest
anonymous
Guest
This is the biggest lie in the company, aside from "we are family" and "we are in this together", HAHAHA that is rich JS (75% TURNOVER loser). First they think reach and frequency works in rare disease, "just call on more people, that will do the trick", dumb asses. Me thinks these little jap boys, who have NEVER had a product in the U.S. and have licensed everything out, can do two things, count scripts, and count calls (or at least the ones reported), so I am willing to bet JS and others are paid on national call average. So a wink and nod latter, they are telling people to just get 4.5 calls a day (no matter if they are legit or not) so the douche bags can hit their quota and fool the boys back in the mother land. Problem is, as it always is. NO ONE can see 4.5 customers a DAY. If you get 4.5 good calls in a week, its a good week, and that is rare. These jack asses are counting calls like they matter, THEY DON'T, big pharma douche bags. Please go away and leave rare disease to the people who know how to do it. So 50%-60% of the calls being reported are BULLSHIT. Which is all fine and well, until........................they start scrutinizing the calls, which they are NOW doing, because, guess what, sales suck, so.....................vicious circle, same ole shit